NCT00649818View on ClinicalTrials.gov

Fasting Study of Lorazepam Tablets 2 mg and Ativan Tablets 2 mg

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

December 31, 2004

Study Completion Date

December 31, 2004

Conditions
Healthy
Interventions
DRUG

Lorazepam Tablets 2 mg

2mg, single dose fasting

DRUG

Ativan Tablets 2 mg

2mg, single dose fasting

Trial Locations (1)

26505

Kendle International Inc., Morgantown

Sponsors
All Listed Sponsors
lead

Mylan Pharmaceuticals Inc

INDUSTRY

NCT00649818 - Fasting Study of Lorazepam Tablets 2 mg and Ativan Tablets 2 mg | Biotech Hunter | Biotech Hunter